Correction to: Results of a phase II trial for high-risk neuroblastoma treatment protocol JN-H-07: a report from the Japan Childhood Cancer Group Neuroblastoma Committee (JNBSG)
Int J Clin Oncol. 2020 Sep;25(9):1744-1745.
doi: 10.1007/s10147-020-01752-4.
1 Children's Cancer Center, National Center for Child Health and Development, 2-10-1 Okura, Setagaya-ku, Tokyo, 157-8535, Japan. tomoro.hishiki@gmail.com.
2 Pediatric Surgical Oncology, National Cancer Center Hospital, Tokyo, Japan. tomoro.hishiki@gmail.com.
3 Children's Cancer Center, National Center for Child Health and Development, 2-10-1 Okura, Setagaya-ku, Tokyo, 157-8535, Japan.
4 Research Institute for Clinical Oncology, Saitama Cancer Center, Saitama, Japan.
5 Pediatrics, National Center for Global Health and Medicine, Tokyo, Japan.
6 Pediatric Surgery, Keio University School of Medicine, Tokyo, Japan.
7 Pediatric Surgery, Osaka City General Hospital, Osaka, Japan.
8 Kobe Proton Center, Kobe, Japan.
9 Pathology, National Center for Child Health and Development, Tokyo, Japan.
10 Clinical Epidemiology Research Center for Pediatric Cancer, National Center for Child Health and Development, Tokyo, Japan.
11 Biostatistics, Kyoto Prefectural University of Medicine, Kyoto, Japan.
12 National Institute of Public Health, Saitama, Japan.
13 Pediatrics, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.
14 Hematology and Oncology, Tokyo Metropolitan Children's Medical Center, Tokyo, Japan.
15 Pediatric Hematology and Oncology, Osaka City General Hospital, Osaka, Japan.
16 Ibaraki Prefectural Association of Health Evaluation and Promotion, Mito, Japan.
17 Pediatric Surgery, Dokkyo Medical University Koshigaya Hospital, Koshigaya, Japan.
18 Pediatric Surgery, Kyoto Prefectural University of Medicine, Kyoto, Japan.
19 Saga Medical Center, KOSEIKAN Hospital, Saga, Japan.